1. Guyre PM, Girard MT, Morganelli PM, et al. Glucocorticoid effects on the production and actions of im-mune cytokines. J Steroid Biochem. 1988;30:89-93.
2.
2. Beutler B, Krochin N, Milsark IW, et al. Control of cachetin (tumor necro-sis factor) synthesis: mechanisms of endotoxin resistance. Science. 1986;232:977-980.
3.
3. Kelley J. Cytokines of the lung. Am Rev Respir Dis. 1990;141:765-788.
4.
4. Bitterman PB, Adelberg S, Crystal RG. Mechanisms of pulmonary fibrosis. Spontaneous release of the alveolar macrophage-derived growth factor in the interstitial lung disorders. J Clin Invest.1983;72:1801-1813.
5.
5. Lacronique JG, Rennard SI, Bitter-man PB, et al. Alveolar macrophages in idiopathic pulmonary fibrosis have glucocorticoid receptors, but glu-cocorticoid therapy does not suppress alveolar macrophage release of fi-bronectin and alveolar macrophage derived growth factor. Am Rev Respir Dis. 1984;130:450-456.
6.
6. Haslett C. Resolution of acute inflam-mation and the role of apoptosis in the tissue fate of granulocytes. Clin Sci. 1992;83:639-648.
7.
7. Borok Z, Buhl R, Grimes GJ, et al. Effect of glutathione aerosol on oxidant-antiox-idant imbalance in idiopathic pulmon-ary fibrosis. Lancet. 1991;338:215-216.
8.
8. Cantin AM, Hubbard RC, Crystal RG. Glutathione deficiency in the epithe-lial lining fluid of the lower respiratory tract in idiopathic pulmonary fibrosis. Am Rev Respir Dis. 1989;139:370-372.
